ONAcom Profile Banner
OncologyNurseAdvisor Profile
OncologyNurseAdvisor

@ONAcom

Followers
6K
Following
768
Media
1K
Statuses
18K

Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.

New York, NY
Joined April 2009
Don't wanna be here? Send us removal request.
@ONAcom
OncologyNurseAdvisor
2 hours
Hereditary breast and #ovariancancer genetic testing uptake were low among underserved women being screened for #breastcancer. Published in @OncJournal. #gyncsm #bcsm.
Tweet card summary image
oncologynurseadvisor.com
Researchers sought to improve HBOC genetic testing in underserved areas through cancer risk assessment at mammography.
0
0
0
@ONAcom
OncologyNurseAdvisor
1 day
ICI therapy was associated with a greater frequency of certain MACEs, such as myocarditis and pericarditis, in patients with primary #lungcancer identified in a nationwide database in Japan. Reported in @OncJournal. #lcsm.
Tweet card summary image
oncologynurseadvisor.com
Patients with lung cancer treated with immune checkpoint inhibitors are at significantly higher risk for certain major cardiovascular adverse events.
0
0
0
@ONAcom
OncologyNurseAdvisor
2 days
RT @TuftsMedicalCtr: Adolescents and young adults face wide-ranging challenges after blood cancer, especially financial ones. A study co-au….
Tweet card summary image
oncologynurseadvisor.com
Many young adult survivors of childhood hematologic cancer do not have comprehensive survivorship care summaries or believe they need one.
0
3
0
@ONAcom
OncologyNurseAdvisor
2 days
Researchers developed a new risk prediction model for methotrexate-related neurotoxicity in young patients being treated for acute #lymphoblasticLeukemia. Reported in @OncJournal. #leusm.
Tweet card summary image
oncologynurseadvisor.com
Study identifies the characteristics that predict risk for methotrexate-related neurotoxicity in young patients being treated for ALL.
0
0
0
@ONAcom
OncologyNurseAdvisor
3 days
In a study of more than 6 million #cancersurvivors, about 1 in 12 reported using #cannabis, and nearly half of them said they used cannabis for medical reasons. Published in @JCOOP_ASCO and @CancerTherAdvsr.
Tweet card summary image
oncologynurseadvisor.com
“Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.
0
0
1
@ONAcom
OncologyNurseAdvisor
4 days
Early oncologic outcomes after RP for very high risk #prostatecancer appear better when patients are staged using PSMA-PET rather than conventional imaging. Presented at #AUA2025. #pcsm.
Tweet card summary image
oncologynurseadvisor.com
Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.
0
0
0
@ONAcom
OncologyNurseAdvisor
5 days
Early dynamic variation in the neutrophil-to-lymphocyte ratio during IMRT accurately predicted radiation-induced hepatic toxicity in patients with #hepatocellularCarcinoma. Published in @RareDisease_Adv. #HCC.
Tweet card summary image
oncologynurseadvisor.com
A higher NLR and rapid NLR shift between weeks 2 and 4 was strongly associated with RILD risk in patients with HCC.
0
0
0
@ONAcom
OncologyNurseAdvisor
6 days
Sociodemographic disparities affect the uptake of the 2021 United States Preventive Services Task Force’s recommendation to begin #colorectalCancer screening at age 45 years. Published in @DCRjournal and @Gastro_Advisor. #crcsm.
Tweet card summary image
oncologynurseadvisor.com
Researchers sought to identify social and structural disparities in the uptake of colorectal cancer screening among adults aged 45 years.
0
0
0
@ONAcom
OncologyNurseAdvisor
7 days
Children with CNS NGGCTs may have better #IQrecovery if they receive proton radiotherapy rather than photon radiotherapy. Presented at @ASCO conference #ASCO2025, covered by @CancerTherAdvsr.
Tweet card summary image
oncologynurseadvisor.com
“To our knowledge, this is the first study that demonstrates a clinical advantage of proton therapy for NGGCT,” said David Y. Mak, MD.
0
0
0
@ONAcom
OncologyNurseAdvisor
8 days
The discharge of pediatric patients after HSCT is a complex and often tenuous process, but a multidisciplinary approach can better prepare patients and their caregivers for the transition from hospital to home. Reported in @NursRep_MDPI. #hemonc.
Tweet card summary image
oncologynurseadvisor.com
A dedicated discharge team, standardized education, a mandatory 24-hour room-in for caregivers, and appointments with a pharmacist are features that ensure a safe transition from hospital to home for...
0
0
0
@ONAcom
OncologyNurseAdvisor
9 days
The survivorship experience of young adults, as well as adolescents and children, who have had #bloodcancer varies widely, necessitating carefully tailored interventions to meet their specific needs. Published in @MASCC_JSCC. #AYACancer.
Tweet card summary image
oncologynurseadvisor.com
Many young adult survivors of childhood hematologic cancer do not have comprehensive survivorship care summaries or believe they need one.
0
0
0
@ONAcom
OncologyNurseAdvisor
10 days
Topline results were announced from a phase 3 trial evaluating a pembrolizumab-based regimen for the treatment of platinum-resistant recurrent #ovariancancer. From @eMPR and @BusinessWire. #gyncsm.
Tweet card summary image
oncologynurseadvisor.com
Among patients whose tumors express PD-L1, a statistically significant and clinically meaningful improvement in overall survival was observed.
0
0
0
@ONAcom
OncologyNurseAdvisor
11 days
Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term #adverseEffects such as second malignancies and infertility, according to researchers. Reported in @NatureGenet and @CancerTherAdvsr.
0
1
2
@ONAcom
OncologyNurseAdvisor
12 days
Surgical interval and post-biopsy surgical interval durations do not significantly affect overall prognosis in patients with cutaneous #melanoma. From @DermAdvisor. #melsm.
Tweet card summary image
oncologynurseadvisor.com
Researchers examined the affect of surgical interval duration on the prognosis of patients with cutaneous melanoma.
0
0
0
@ONAcom
OncologyNurseAdvisor
14 days
Omitting pelvic lymphadenectomy may be beneficial for patients with early-stage #cervicalcancer undergoing sentinel lymph node biopsy and radical hysterectomy. Presented at the #ASCO2025, covered by @CancerTherAdvsr. #gyncsm.
Tweet card summary image
oncologynurseadvisor.com
Undergoing sentinel lymph node biopsy and radical hysterectomy without pelvic lymphadenectomy may reduce the risk of retroperitoneal nodal recurrence and cancer-specific death.
0
0
2
@ONAcom
OncologyNurseAdvisor
15 days
A team-based model employing registered nurses and nursing technicians to provide home-based #palliativecare is a cost-effective model of providing care to patients with advanced #cancer at the end of life.
Tweet card summary image
oncologynurseadvisor.com
SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas.
0
0
1
@ONAcom
OncologyNurseAdvisor
16 days
Most patients with newly diagnosed #cervicalcancer lack baseline knowledge of palliative care, yet the majority respond favorably to early integration of these services after a brief educational intervention. Published in @gynoncjnls. #gyncsm.
Tweet card summary image
oncologynurseadvisor.com
Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.
0
0
1
@ONAcom
OncologyNurseAdvisor
17 days
HER3-DXd demonstrated some activity in a phase 3 trial of patients with previously treated, EGFR-mutant #NSCLC, but a lack of OS benefit prompted the withdrawal of the BLA for the antibody-drug conjugate. From @CancerTherAdvsr . #lcsm.
Tweet card summary image
oncologynurseadvisor.com
HER3-DXd demonstrated activity in a phase 3 trial of patients with previously treated, EGFR-mutant NSCLC, but the BLA for HER3-DXd has been withdrawn.
0
1
3